NCT01171300View on ClinicalTrials.gov

Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2025

Conditions
AdenocarcinomaRectal Neoplasms
Interventions
OTHER

18F- FDG PET scans

We aim to investigate the value of FGD-PET for evaluating response before surgery. To achieve this, the patients will undergo 3 FDG-PET scans (at moment of diagnosis (staging), during chemoradiation (early response), 1-2 weeks before surgery (restaging))

OTHER

DW-MRI scans

We aim to investigate the value of DW-MRI for evaluating response before surgery. To achieve this, the patients will undergo 3 FDG-PET scans (at moment of diagnosis (staging), during chemoradiation (early response), 1-2 weeks before surgery (restaging))

Trial Locations (1)

3000

University Hospitals Gasthuisberg, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01171300 - Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients | Biotech Hunter | Biotech Hunter